1.72
price up icon6.17%   0.10
pre-market  Vorhandelsmarkt:  1.75   0.03   +1.74%
loading
Schlusskurs vom Vortag:
$1.62
Offen:
$1.63
24-Stunden-Volumen:
390.54K
Relative Volume:
0.48
Marktkapitalisierung:
$171.99M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-1.3984
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
+10.97%
1M Leistung:
+17.01%
6M Leistung:
-3.37%
1J Leistung:
-73.00%
1-Tages-Spanne:
Value
$1.62
$1.74
1-Wochen-Bereich:
Value
$1.53
$1.74
52-Wochen-Spanne:
Value
$0.87
$6.78

Alector Inc Stock (ALEC) Company Profile

Name
Firmenname
Alector Inc
Name
Telefon
415-231-5660
Name
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Name
Mitarbeiter
175
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-05
Name
Neueste SEC-Einreichungen
Name
ALEC's Discussions on Twitter

Vergleichen Sie ALEC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ALEC
Alector Inc
1.72 154.99M 100.56M -119.05M -231.16M -1.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Alector Inc Stock (ALEC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-17 Herabstufung Mizuho Outperform → Neutral
2024-12-16 Herabstufung Stifel Buy → Hold
2024-12-04 Herabstufung BofA Securities Neutral → Underperform
2024-11-29 Bestätigt H.C. Wainwright Buy
2024-11-26 Herabstufung Morgan Stanley Equal-Weight → Underweight
2023-12-14 Hochstufung Stifel Hold → Buy
2023-12-12 Eingeleitet Deutsche Bank Buy
2023-09-25 Eingeleitet Goldman Sell
2023-09-22 Eingeleitet Cantor Fitzgerald Overweight
2023-01-06 Herabstufung BofA Securities Buy → Neutral
2022-09-09 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-07-07 Eingeleitet Mizuho Buy
2022-04-13 Eingeleitet Goldman Sell
2022-03-08 Herabstufung Stifel Buy → Hold
2021-09-27 Eingeleitet William Blair Outperform
2021-01-15 Fortgesetzt BofA Securities Buy
2020-06-24 Eingeleitet H.C. Wainwright Buy
2020-04-28 Eingeleitet Goldman Buy
2020-03-06 Eingeleitet Citigroup Buy
2020-02-27 Eingeleitet Barclays Overweight
2020-02-19 Eingeleitet Stifel Buy
2019-11-21 Eingeleitet BTIG Research Buy
2019-03-04 Eingeleitet Barclays Overweight
2019-03-04 Eingeleitet BofA/Merrill Buy
2019-03-04 Eingeleitet Morgan Stanley Overweight
2019-03-04 Eingeleitet SVB Leerink Outperform
Alle ansehen

Alector Inc Aktie (ALEC) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Alector Inc. stockSuperior capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Alector Inc. Stock Analysis and ForecastTurbocharged investment results - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Alector Inc. stock priceBreakthrough wealth creation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Is Alector Inc. a good long term investmentConsistently superior profits - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

5 Undervalued AI Stocks Set for a Second-Half 2025 Rebound - AInvest

Jul 20, 2025
pulisher
Jul 15, 2025

What makes Alector Inc. stock price move sharplyFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Alector Inc. stock attracts strong analyst attentionLong Term Safe Yield Focus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Alector Inc. stock performs during market volatilityFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

3 Penny Stocks With Market Caps Over $80M To Watch Closely - simplywall.st

Jul 11, 2025
pulisher
Jun 30, 2025

Kyverna Therapeutics appoints Marc Grasso as CFO - MSN

Jun 30, 2025
pulisher
Jun 14, 2025

Alector appoints Neil Berkley as interim CFO - MSN

Jun 14, 2025
pulisher
Jun 14, 2025

Alector (ALEC) Appoints Interim CFO as Current CFO Departs | ALE - GuruFocus

Jun 14, 2025
pulisher
Jun 14, 2025

Alector Provides Executive Leadership Update | ALEC Stock News - GuruFocus

Jun 14, 2025
pulisher
Jun 14, 2025

Alector, Inc. (NASDAQ:ALEC) Given Consensus Rating of “Hold” by Brokerages - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Alector Names Neil Berkley as Interim CFO - MarketScreener

Jun 13, 2025
pulisher
Jun 13, 2025

Alector Provides Executive Leadership Update - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

Alector, Inc. (NASDAQ:ALEC) Position Increased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Alector Appoints CBO Neil Berkley as Interim CFO Amid Crucial Phase 3 Trial Progress - Stock Titan

Jun 13, 2025
pulisher
Jun 11, 2025

Alector shares surge 73% following InvestingPro’s April fair value signal By Investing.com - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Forecasts Alector FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Transcript : Alector, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - marketscreener.com

Jun 10, 2025
pulisher
Jun 06, 2025

Alector, Inc. (NASDAQ:ALEC) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Alector president sells shares worth $31,974 - Investing.com Australia

Jun 05, 2025
pulisher
Jun 05, 2025

Alector president sells shares worth $31,974 By Investing.com - Investing.com Canada

Jun 05, 2025
pulisher
Jun 04, 2025

Alector Executives Sell Shares to Cover Tax Obligations - TradingView

Jun 04, 2025
pulisher
Jun 03, 2025

Are Investors Inclined To Sell Their Alector Inc (NASDAQ: ALEC) Holdings? - Stocksregister

Jun 03, 2025

Finanzdaten der Alector Inc-Aktie (ALEC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):